Inflacam Chewable Tablets for Dogs

Inflacam Chewable Tablets are used to relieve inflammation and pain in dogs. Inflacam can be used for chronic (long-term) musculoskeletal disorders, and acute (sudden and short-lived) musculoskeletal disorders, for instance, due to injury.

It is also used for the reduction of post-operative pain and inflammation after soft tissue surgery.

Contra-indications 

• Do not use in pregnant or lactating animals.
• Do not use in dogs suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
• Do not use in case of hypersensitivity to the active substance or to any of the excipients.
• Do not use in dogs less than 6 weeks of age.

Special precautions for use

Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

People with known hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) should avoid contact with the veterinary medicinal product.

In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Adverse reactions

Typical adverse reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, lethargy and renal failure have occasionally been reported. In very rare cases haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported.

These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.

If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.

Does Inflacam make dogs drowsy? There is no evidence that Inflacam makes dogs drowsy.

Use of Inflacam chewable tablets for dogs during pregnancy and lactation

The safety of the veterinary medicinal product has not been established during pregnancy and lactation (see section 4.3).

Interactions

Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. Inflacam must not be administered in conjunction with other NSAIDs or glucocorticosteroids.

Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such veterinary medicinal products should be observed for at least 24 hours before commencement of treatment. The treatment-free period, however, should take into account the pharmacokinetic properties of the veterinary products used previously.

Inflacam chewable tablets for dogs dosage

Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight.

For longer term treatment, once clinical response has been observed (after ≥ 4 days), the dose of Inflacam can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.

Particular care should be taken with regard to the accuracy of dosing.

To be administered orally either mixed with food or directly into the mouth.

A clinical response is normally seen within 3–4 days. Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.

Avoid introduction of contamination during use.

Inflacam for dogs can be used alongside joint supplements. You can purchase them here

SPC and data sheet

Please select the number of tablets written on your prescription.